Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $79.75M
Founded date: 2017
Investors 1
Date | Name | Website |
- | Alpha Wave... | alphawaveg... |
Funding Rounds 1
Date | Series | Amount | Investors |
04.01.2023 | Series C | $79.75M | - |
Mentions in press and media 9
Date | Title | Description | Source |
06.03.2024 | Apnimed to Participate in the Upcoming Leerink Partners Glob... | - | globenewsw... |
04.01.2023 | Cambridge-based pharmaceutical based firm Apnimed Inc raises... | CAMBRIDGE, MASSACHUSETTS— Apnimed, Inc., the clinical-stage pharmaceutical company focused on develo... | vcbay.news... |
04.01.2023 | Apnimed Completes $79.75M Series C Extension Financing | Ampimed, a Cambridge, MA-based clinical-stage pharmaceutical company, raised $79.75M in Series C ext... | finsmes.co... |
03.01.2023 | Apnimed Inks $79.75M Oversubscribed Series C | CAMBRIDGE, MA, Apnimed announced today that it has secured $79.75 million in an oversubscribed fin... | vcnewsdail... |
04.05.2022 | Apnimed closes $62.5M series C after working tirelessly on l... | Apnimed isn’t resting on its laurels. A year after its series B financing, the clinical-stage pharma... | fiercebiot... |
25.03.2021 | Apnimed raises $25M to take sleep apnea drug into phase 3 | Apnimed has raised $25 million to develop a pharmacological treatment for obstructive sleep apnea (O... | fiercebiot... |
25.03.2021 | Apnimed raises $25M to take sleep apnea drug into phase 3 | Apnimed has raised $25 million to develop a pharmacological treatment for obstructive sleep apnea (O... | fiercebiot... |
- | Apnimed | “Apnimed - Changing the Way We Treat OSA” | fastfounde... |
- | Ex-Athira Pharma CEO Leen Kawas Starts $150M Fund With Key I... | Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation fou... | dot.la/ex-... |